glp-1 brain Frontiers GLP-1 medications may only temporarily
Description
WY and A-MX contributed to the conception, design, and revision of the manuscript
Also, no significant difference was seen between the exenatide and pooled comparator (placebo and insulin) groups (95% CI: -0.98 to 0.96) [152]
Risks of Off-Label Use and Compounded GLP-1 Drugs Off-label use, using a drug to treat a condition its not approved for, can result in adverse reactions
For veterans, athletes, and anyone serious about their health, this level of transparency is non-negotiable
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes
n.s., not significant
